Loading
Abingworth LLP is a prominent life sciences investment firm founded in 1973, focused on transforming scientific discoveries into innovative medicines and treatments. As part of the global investment firm Carlyle, Abingworth manages over $1.25 billion across various life sciences funds, including its 11th fund and the Clinical Co-Development Co-Investment Fund. The firm has a strong investment track record, having invested in over 185 life science companies, resulting in more than 75 IPOs and over 50 mergers and acquisitions. Abingworth specializes in investment management and strategic collab